RELMADA THERAPEUTICS INC's ticker is RLMD and the CUSIP is 75955J402. A total of 90 filers reported holding RELMADA THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is 0.59 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $65,028 | +37.9% | 21,676 | +13.0% | 0.01% | +42.9% |
| Q2 2023 | $47,173 | +66.2% | 19,176 | +52.7% | 0.01% | +40.0% |
| Q1 2023 | $28,388 | +7.2% | 12,561 | +65.6% | 0.01% | 0.0% |
| Q4 2022 | $26,472 | -86.5% | 7,585 | +43.5% | 0.01% | -86.8% |
| Q3 2022 | $196,000 | +70.4% | 5,285 | -13.1% | 0.04% | +65.2% |
| Q2 2022 | $115,000 | -29.9% | 6,081 | 0.0% | 0.02% | -23.3% |
| Q1 2022 | $164,000 | +8.6% | 6,081 | -9.0% | 0.03% | +7.1% |
| Q4 2021 | $151,000 | +4.1% | 6,681 | +20.8% | 0.03% | -3.4% |
| Q3 2021 | $145,000 | +4.3% | 5,531 | +27.6% | 0.03% | 0.0% |
| Q2 2021 | $139,000 | -9.2% | 4,335 | 0.0% | 0.03% | -14.7% |
| Q1 2021 | $153,000 | +10.1% | 4,335 | 0.0% | 0.03% | +6.2% |
| Q4 2020 | $139,000 | -3.5% | 4,335 | +13.0% | 0.03% | -8.6% |
| Q3 2020 | $144,000 | -16.3% | 3,835 | 0.0% | 0.04% | -20.5% |
| Q2 2020 | $172,000 | +31.3% | 3,835 | 0.0% | 0.04% | +15.8% |
| Q1 2020 | $131,000 | +15.9% | 3,835 | +32.2% | 0.04% | +40.7% |
| Q4 2019 | $113,000 | – | 2,900 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Guild Investment Management, Inc. | 205,300 | $615,900 | 1.03% |
| Deep Track Capital, LP | 2,837,818 | $8,513,454 | 0.33% |
| PARSONS CAPITAL MANAGEMENT INC/RI | 974,082 | $2,922,246 | 0.23% |
| apricus wealth, LLC | 77,362 | $239,822 | 0.21% |
| Palo Alto Investors LP | 732,400 | $2,197,200 | 0.21% |
| RTW INVESTMENTS, LP | 2,131,835 | $6,395,505 | 0.14% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 100,000 | $300,000 | 0.09% |
| AdvisorShares Investments LLC | 112,908 | $338,724 | 0.09% |
| Savior LLC | 3,500 | $10,500 | 0.07% |
| Spotlight Asset Group, Inc. | 20,000 | $60,000 | 0.05% |